Investment Rating - The report indicates a preference for Beverage, followed by Pet Foods, Beer, and Dairy, with specific stock ideas highlighted for Eastroc, Tingyi/CR beverage, and Tsingtao-H [9][10]. Core Insights - The industry is experiencing a bumpy recovery in demand, particularly in the spirits, beer, and dairy sectors, with recent policy changes impacting consumption sentiment [1][3]. - Emerging channel shifts, such as instant shopping and discounter channels, are gaining traction, although their overall contribution to the staples universe remains small [1][8]. - Profitability resilience is supported by cost deflation and agile investment strategies, with companies focusing on margin visibility amid muted demand trends [1][9]. Demand Recovery - The demand recovery in Q2 has been lackluster, with notable declines in spirits and dairy products, while beer performance varies across brands [2][11]. - Retail performance has been conservative, with spirits and dairy showing year-over-year declines, particularly in the upper mid-end segments [2][11]. - The beverage sector shows solid volume momentum, although mixed performance is noted across brands [2][11]. Policy Impact - Recent policy tightening on alcohol consumption has created headwinds for spirits and beer companies, particularly affecting high-end catering and on-trade consumption [3][6][34]. - The government has implemented regulations prohibiting the serving of alcoholic drinks during working meals, impacting consumption sentiment during peak seasons [3][6][34]. Emerging Trends - There is a notable shift towards discounter channels and instant shopping platforms, with companies customizing products to meet rising demand [8][10]. - The pet food and beverage categories are experiencing positive product cycles, contributing to growth despite overall market challenges [7][41]. Pricing and Cost Trends - Pricing pressures persist across various sectors, with dairy and beverages introducing more value-for-money products in response to declining raw milk prices [12][36]. - Cost benefits from declining commodity prices are expected to support margin resilience across multiple sectors, including beer and dairy [7][12]. Company Performance - Companies like Yili and Mengniu are facing weak demand trends in UHT liquid milk, while fresh milk and chilled yogurt categories are performing better [38]. - CR Beer and Chongqing Brewery are focusing on in-home consumption and premiumization strategies to counteract weak on-trade demand [35][40]. - The pet food sector remains strong, with companies like China Pet expecting significant year-over-year growth driven by new product launches [41].

Investment Rating - The report indicates a solid total food sales growth of +2.8%/+3.2% year-over-year for the latest 4 weeks and 12 weeks, aligning with the long-term trend of low single-digit growth [1][6]. Core Insights - Total food sales growth is primarily driven by pricing, although there is a noted decline in volumes across most packaged food categories, with HSY being an exception due to pricing support [1][9]. - All companies within the coverage have lost market share in their top categories, indicating competitive pressures [1][10]. Department & Category Detail - Total food sales increased by +2.8% year-over-year in the latest 4 weeks, with private label products leading in most categories [2]. - Total equivalent (EQ) units decreased by -0.5% year-over-year, with branded products slightly outperforming private label products [2][5]. - Yogurt and packaged coffee showed the highest sales growth at +13.5% and +13.4% year-over-year, respectively, with private label sales growth strongest in snack/variety packs, meal combos, and packaged coffee [5][7]. Company Performance - CAG reported a sales decline of -1% year-over-year, driven by lower prices, while volumes remained flat [9]. - GIS experienced a -2% year-over-year sales decline, attributed to lower volumes [10]. - HSY saw a sales increase of +5% year-over-year, supported by higher prices and volumes [11]. - K reported a -3% year-over-year sales decline, primarily due to lower volumes [12]. - KHC's sales declined by -4% year-over-year, with lower volumes impacting performance [13]. - MDLZ reported a -1% year-over-year sales decline, driven by lower prices [14]. - SFD experienced a -1% year-over-year sales decline, although packaged lunchmeat showed strong growth [15].

10 June 2025 | 12:43PM EDT Americas Consumer Products NielsenIQ data thru 5/31 - US Cosmetics sales inflect positively in latest 2-wk period Our View - US cosmetics & nails sales in Nielsen (incl Amazon 1P) grew +0.6% in the latest 2-wks ended 5/31 (vs -0.2%/-1.6% for 4-/12-wks), reflecting -LSD pressure on volumes against +LSD pricing. By category, lip cosmetics outperformed other categories, growing +9.5% (vs +7.7%/+5.6% for 4-/12-wks) on strong volume growth of +9.8% (vs +8.4%/+5.2% for 4-/12-wks). Face ...

Investment Rating - The investment rating for Insulet Corp. is "Buy" with a 12-month price target of $380, indicating an upside potential of 24.3% from the current price of $305.66 [9]. Core Insights - Insulet Corp. aims to increase penetration in Type 1 diabetes patients, ramp up adoption in the Type 2 population, and expand internationally while targeting at least 100 basis points of annual operating margin expansion [1][4]. - The company has a strong performance track record, having exceeded original guidance by an average of 7.5% in 2022, 2023, and 2024 [1]. - The recent CEO transition does not signal a change in strategy, with continued focus on U.S. Type 1 adoption and growth in the Type 2 opportunity [4][6]. - The 2025 sales guidance appears conservative, reflecting a cautious outlook despite a strong first quarter performance [4][5]. Summary by Sections Strategic Priorities - Insulet Corp. is focused on increasing its market share in Type 1 diabetes, accelerating growth in the Type 2 segment, and expanding its international footprint [1][4]. - The company plans to enhance its Omnipod 5 rollout in additional countries, with nine new countries targeted for early 2025 [7]. Financial Performance - The company reported a gross margin of 71.9% in Q1 2025, with expectations to maintain around 71% for the full year, reflecting strong manufacturing efficiencies [7]. - Revenue projections for 2025 are estimated at $2.57 billion, with continued growth anticipated in subsequent years [9]. Market Opportunities - The Type 2 diabetes market shows early momentum with only ~5% penetration of the estimated 2.5 million patients in the U.S., indicating significant growth potential [7]. - Internationally, Insulet has only achieved 20% penetration in its current markets, suggesting ample opportunity for expansion [7]. Valuation - The valuation is based on a next twelve months (NTM) price-to-earnings (P/E) multiple of 65.0x applied to earnings per share (EPS) estimates [6].

Investment Rating - The report assigns a "Buy" rating to several companies within the Taiwan Technology sector, including Wiwynn, Wistron, Hon Hai, Gigabyte, and various AI server components [25]. Core Insights - The Taiwan Technology sector is experiencing strong growth in ASIC AI servers and related components, with notable revenue increases reported by key players such as Wiwynn (+187% YoY) and Gigabyte (+108% YoY) [1][8]. - The report highlights a transition in server models expected in 3Q25, with a cautious outlook on rack-level AI server shipments due to macro uncertainties [9]. - The demand for components like liquid cooling, silicon photonics, rail kits, and chassis is anticipated to rise, driven by specification upgrades and the increasing adoption of AI technologies [9][10]. Summary by Sections ASIC AI Servers and Components - ASIC AI servers are showing robust growth, with Wiwynn's revenues up 187% YoY, significantly exceeding estimates [1][8]. - Baseboard-based AI servers also demonstrate strong performance, with Gigabyte achieving 108% YoY revenue growth [1][8]. - Liquid cooling solutions are gaining traction, with AVC reporting 87% YoY revenue growth [1][8]. Market Outlook - The report expresses caution regarding rack-level AI server shipments in the second half of 2025, while maintaining a positive outlook for ASIC and baseboard-based AI servers [9]. - The global market for AI servers is projected to reach 19,000 racks by 2025, indicating a significant growth opportunity [9]. Non-AI Sector Insights - The smartphone supply chain is expected to strengthen in 3Q25, with new high-end models being prepared for launch [10]. - AI PCs are anticipated to see continued penetration, with brands like ASUS and Lenovo leading the charge [10]. Investment Opportunities - Recommended investments include AI server ODMs and brands such as Wiwynn, Wistron, Hon Hai, and Gigabyte, as well as components like AVC, Fositek, and LandMark [11].

Investment Rating - The report does not explicitly provide an investment rating for Longsys (301308.SZ) [1] Core Insights - Longsys is expanding into the enterprise market, driven by increasing demand for high-bandwidth and low-latency storage solutions, particularly due to rising AI capital expenditures in China and the growing adoption of edge devices [1][2] - The company is also developing in-house memory controller ICs and UFS chipsets, with expectations for shipment ramp-up in 2025 [1][4] Summary by Sections Company Overview - Longsys (301308.SZ) is a Chinese company specializing in NAND flash and DRAM module design, providing embedded memory, SSDs, memory cards, and DRAM modules to global markets, targeting consumer, automotive, and enterprise sectors [3] 2025 Outlook - Management anticipates growing demand for high-speed storage solutions from cloud service providers (CSPs) and upgrades in edge devices to support AI applications, which is expected to positively impact enterprise storage business growth [4] - Revenue growth slowed in the second half of 2024 and the first quarter of 2025 due to soft demand, but management expects enhanced AI capabilities to drive user adoption and revenue growth in 2025 [4] Enterprise Market Expansion - Longsys has initiated volume shipments of enterprise storage solutions, achieving a 666% year-over-year increase in enterprise storage revenues to RMB 922 million in 2024, representing approximately 5% of total revenues [8] - The company has developed various solutions for enterprise clients, including MRDIMM, PCIe eSSD, SATA ESSD, and DDR5 RDIMM, focusing on the demands of AI computing platforms [8] Memory Controller IC Development - Longsys is transitioning from memory modules to memory controller ICs through in-house development, having started shipments of three controller IC products with over 30 million units shipped [8] - The company is also developing in-house UFS chipsets with speeds of 4350 MB/s, with expectations for accelerated shipment ramp-up starting in 2025 [8]

Investment Rating - The report does not explicitly provide an investment rating for the industry Core Insights - High-skilled immigrants, defined as those who arrived in the US for college or after earning a degree elsewhere, significantly contribute to the US economy through innovation, productivity, and fiscal impact [3][4][30] - High-skilled immigrants account for approximately 5% of the US labor force but represent a larger share in industries requiring advanced education, such as information services and pharmaceuticals [3][15] - The median annual earnings for high-skilled immigrants are about $20k higher than their college-educated native-born counterparts in the top 20 industries where they are most prevalent [19][25] Employment and Earnings - As of 2023, there were approximately 8.2 million high-skilled immigrants in the US, up from 3.4 million in 2015, representing 5% of the labor force [8][6] - High-skilled immigrants who came to the US for college earn roughly $15k more annually than those who arrived later and college-educated native-born workers [19][22] - In industries with a high concentration of high-skilled immigrants, median annual earnings for these workers are significantly higher than for their native-born counterparts [25][28] Innovation and Business Formation - High-skilled immigrants constitute 13% of the STEM workforce and hold 29% of US Nobel Prizes, indicating their substantial role in innovation [30][33] - They are responsible for 20% of venture capital-backed startups and patent at double the rate of native-born inventors [35][30] - High-skilled immigrants contribute to 36% of aggregate innovation, as measured by patent citations [35][30] Fiscal Effects - Each additional high-skilled immigrant is estimated to lower the federal budget deficit by approximately $75k over ten years, with those in STEM fields contributing even more [39][40] - The entire stock of high-skilled immigrants in the US is estimated to exert $50-80 billion in downward pressure on the federal deficit annually [40][39] Spillover Effects - The spillover effects of high-skilled immigrants on native-born workers vary, with some studies indicating positive impacts on wages and employment for native workers [41][46] - High-skilled immigrants are associated with increased innovation among native-born inventors, contributing to a higher rate of patenting activity [43][46]

Investment Rating - The report does not provide a specific investment rating for Ingenic (300223.SZ) as it is categorized as Not Covered [1]. Core Insights - Ingenic management is optimistic about a growth recovery in 2025 following a weak 2024, with inventory levels stabilizing and demand improving from automotive and industrial sectors [1][4]. - The semiconductor supply chain is transitioning from mature nodes to advanced solutions, driven by technological breakthroughs, which is expected to enhance competition and product mix [2]. - Ingenic is focusing on upgrading its computing chipsets to higher computing power and expanding into 3D DRAM to meet the increasing demand for AI solutions requiring high bandwidth and large capacity [1][9]. Summary by Sections 2025 Outlook - Management anticipates 2024 will be the lowest point due to inventory pressures, with a gradual recovery expected in 2025, supported by improvements in automotive and industrial markets and product upgrades [4]. Computing Chipset Product Mix Upgrade - Ingenic is enhancing its computing chipsets, targeting approximately 1T computing power for consumer electronics and surveillance, and plans to launch the T23 chipset for multi-camera applications, with a future T42 chipset exceeding 2T computing power [5][8]. Memory Chipset Product Expansion - The company offers a range of memory products including SRAM, DRAM, NOR Flash, and is expanding into advanced memory chips. Demand from EU and US markets was weak in 2024, but recovery is expected in 2025, with revenue contributions from new memory technologies anticipated to begin in 2026 [9].

Investment Rating - The report indicates a cautious outlook on oil prices, with Brent expected to average $60 for the rest of 2025 and $56 in 2026 [6]. Core Insights - Brent prices increased by $3 to $67 per barrel due to fading demand fears, downside risks to North American supply, and geopolitical tensions [1] - Mixed signals regarding physical tightness are observed, with rising inventories and OPEC+ supply concerns [4][5] - The US May jobs report suggests a slight economic slowdown, but fears regarding demand have eased as the economy is not in recession [2] Supply and Demand Dynamics - US crude production reached an all-time high of 13.49 million barrels per day (mb/d) in March, despite a significant drop in the US oil rig count [3][26] - Global visible commercial oil stocks have risen by 1.0 mb/d year-to-date, with notable increases in China, the US, and on water [10][4] - Trackable net supply edged down by 0.2 mb/d week-over-week, while trackable inventories rose [14] OPEC+ Supply Signals - OPEC+ supply signals were mixed, with support from supply misses in Russia and Iraq, but downward pressure from Saudi Arabia's desire to increase production [5][8] - The long-to-short oil ratio stands at the 58th percentile, indicating a relatively balanced positioning in the market [76] Price Trends and Forecasts - The average crude basis remains elevated but has edged down slightly, while the average crude prompt timespread has increased [56] - The report suggests that lower-than-anticipated spare capacity represents an upside risk to the price forecast [8]

Investment Rating - The report maintains a "Buy" rating on Mindray and United Imaging, indicating confidence in their growth potential and market positions [96][99]. Core Insights - The procurement value of main medical devices in China showed a strong year-over-year growth of 91% in May 2025, despite a month-over-month decline of 13% [1]. - The report highlights a significant price pressure on ultrasound devices due to regional Value-Based Procurement (VBP), with average bid prices decreasing by approximately 20% compared to the 2024 average [10][12]. - Mindray's revenue is expected to be impacted by around 3% due to VBP pricing pressure, but the company is still projected to maintain robust growth in its end markets [30]. Summary by Sections Procurement Activity - Hospital procurement activity in China has clearly recovered, with a 33% increase in May 2025 compared to May 2023 [1]. - The report anticipates continued high year-over-year growth in procurement activity for June 2025 [1]. Device-Specific Insights - Ultrasound devices experienced a significant average bid price cut of 61% in Henan province, leading to a 20% decrease in average selling price (ASP) in May compared to the 2024 average [10][12]. - Other medical devices, such as CT scanners, are not currently facing similar price pressures as ultrasound devices [10][16]. Company Performance - Mindray reported a year-over-year growth of 52% in patient monitors and 103% in ultrasound devices for May 2025 [30][43]. - United Imaging is optimistic about the trade-in program in 2025, expecting smoother processes compared to 2024, although revenue recognition cycles have lengthened [29][99]. Market Trends - The report notes that both domestic and multinational companies achieved notable year-over-year growth in procurement, indicating a balanced competitive landscape [78]. - The trend of domestic substitution in the medical device market is not particularly evident in May, as both local and multinational companies performed well [78].